MODD

Company Overview — What Does Modular Medical, Inc. Do?

Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. The company is headquartered in San Diego, California. Modular Medical, Inc. (MODD) is classified as a micro-cap stock in the Healthcare sector, specifically within the Medical Equipment industry. The company is led by CEO James E. Besser and employs approximately 20 people. With a market capitalization of $25M, MODD is one of the notable companies in the Healthcare sector.

Modular Medical, Inc. (MODD) Stock Rating — Reduce (April 2026)

As of April 2026, Modular Medical, Inc. receives a Reduce rating with a composite score of 29.3/100 and 2 out of 5 stars from the Blank Capital Research quantitative model.MODD ranks #3,268 out of 4,446 stocks in our coverage universe. Within the Healthcare sector, Modular Medical, Inc. ranks #496 of 838 stocks, placing it in the lower half of its Healthcare peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).

MODD Stock Price and 52-Week Range

Modular Medical, Inc. (MODD) currently trades at $4.91. The stock lost $0.11 (2.2%) in the most recent trading session. The 52-week high for MODD is $1.29, which means the stock is currently trading 280.6% from its annual peak. The 52-week low is $0.12, putting the stock 4047.0% above its annual trough. Recent trading volume was 39K shares, suggesting relatively thin trading activity.

Is MODD Overvalued or Undervalued? — Valuation Analysis

Modular Medical, Inc. (MODD) carries a value factor score of 17/100 in the Blank Capital model, signaling premium valuation that prices in significant future growth. The price-to-book ratio stands at 4.15x, versus the sector average of 2.75x.

At current multiples, Modular Medical, Inc. trades at a premium to most Healthcare peers. This elevated valuation may be justified if the company can sustain above-average growth rates and profitability, but it also creates downside risk if earnings disappoint expectations.

Modular Medical, Inc. Profitability — ROE, Margins, and Quality Score

Modular Medical, Inc. (MODD) earns a quality factor score of 13/100, signaling below-average profitability metrics relative to the broader market. The return on equity (ROE) is -453.3%, compared to the Healthcare sector average of -43.5%, which is below typical expectations for high-quality companies. Return on assets (ROA) comes in at -259.8% versus the sector average of -33.1%.

Profitability is below benchmark levels, which may reflect industry headwinds, elevated reinvestment, or structural challenges.

MODD Debt, Balance Sheet, and Financial Health

Modular Medical, Inc. has a debt-to-equity ratio of 74.0%, compared to the Healthcare sector average of 32.0%. Leverage is within a manageable range for the industry, though investors should monitor debt trends over time. The current ratio is 1.59x, suggesting adequate working capital coverage.

MODD has a beta of -1.74, meaning it is less volatile than the S&P 500, making it a relatively defensive holding. The stability factor score for Modular Medical, Inc. is 27/100, suggesting elevated price swings that may be unsuitable for conservative portfolios.

Modular Medical, Inc. Revenue and Earnings History — Quarterly Trend

In TTM 2026, Modular Medical, Inc. reported revenue of $0 and earnings per share (EPS) of $-0.11. Net income for the quarter was $-27M. Operating income came in at $-27M.

In Q3 2026, Modular Medical, Inc. reported revenue of $0 and earnings per share (EPS) of $-0.11. Net income for the quarter was $-7M. Operating income came in at $-7M.

In Q2 2026, Modular Medical, Inc. reported revenue of $0 and earnings per share (EPS) of $-0.14. Net income for the quarter was $-8M. Operating income came in at $-8M.

In Q1 2026, Modular Medical, Inc. reported revenue of $0 and earnings per share (EPS) of $-0.12. Net income for the quarter was $-7M. Operating income came in at $-7M.

Over the past 8 quarters, Modular Medical, Inc. has experienced revenue contraction from $0 to $0. Investors analyzing MODD stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.

MODD Dividend Yield and Income Analysis

Modular Medical, Inc. (MODD) does not currently pay a dividend. This is common among smaller companies in the Medical Equipment industry that prefer to reinvest cash flows into business expansion rather than returning capital to shareholders. Income-focused investors looking for Healthcare dividend stocks may want to explore other Healthcare stocks or use the stock screener to filter by dividend yield.

MODD Momentum and Technical Analysis Profile

Modular Medical, Inc. (MODD) has a momentum factor score of 43/100, reflecting neutral trend characteristics. The stock is neither significantly outperforming nor underperforming the broader market on a momentum basis. The investment factor score is 25/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 69/100 reflects moderate short selling activity.

MODD vs Competitors — Healthcare Sector Ranking and Peer Comparison

Within the Healthcare sector, Modular Medical, Inc. (MODD) ranks #496 out of 838 stocks based on the Blank Capital composite score. This places MODD in the lower half of all Healthcare stocks in our coverage universe. Key competitors and sector peers include ASTRAZENECA PLC (AZN) with a score of 61.4/100, Sol-Gel Technologies Ltd. (SLGL) with a score of 56.6/100, VIEMED HEALTHCARE, INC. (VMD) with a score of 53.4/100, Innoviva, Inc. (INVA) with a score of 52.7/100, and JOHNSON & JOHNSON (JNJ) with a score of 51.7/100.

Comparing MODD against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full MODD vs S&P 500 (SPY) comparison to assess how Modular Medical, Inc. stacks up against the broader market across all factor dimensions.

MODD Next Earnings Date

No upcoming earnings date has been announced for Modular Medical, Inc. (MODD) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.

Should You Buy MODD? — Investment Thesis Summary

The quantitative profile for Modular Medical, Inc. suggests caution. The quality score of 13/100 flags below-average profitability. The value score of 17/100 indicates premium valuation. High volatility (stability score 27/100) increases portfolio risk.

In summary, Modular Medical, Inc. (MODD) earns a Reduce rating with a composite score of 29.3/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on MODD stock.

Related Resources for MODD Investors

Explore more research and tools: MODD vs S&P 500 comparison, top Healthcare stocks, stock screener, our methodology, quality factor explained, value factor explained, momentum factor explained. Compare MODD head-to-head with peers: MODD vs AZN, MODD vs SLGL, MODD vs VMD.